Application

PTO- 1478

Approved for use through 10/31/2024. OMB 0651-0009

U.S. Patent and Trademark Office; U.S. DEPARTMENT OF COMMERCE Under the Paperwork Reduction Act of 1995, no persons are required to respond to a collection of information unless it contains a valid OMB control number

---

PTO- 1478

Approved for use through 10/31/2024. OMB 0651-0009

U.S. Patent and Trademark Office; U.S. DEPARTMENT OF COMMERCE Under the Paperwork Reduction Act of 1995, no persons are required to respond to a collection of information unless it contains a valid OMB control number

Trademark/Service Mark Application, Principal Register

Serial Number: 97800435

Filing Date: 02/17/2023

To the Commissioner for Trademarks:

MARK: NUGO (Standard Characters, see mark)
The literal element of the mark consists of NUGO. The mark consists of standard characters, without claim to any particular font style, size, or color.
The applicant, CENTREXION THERAPEUTICS CORPORATION, a corporation of Delaware, having an address of
      200 STATE STREET, 6TH FLOOR
      Boston, Massachusetts 02109
      United States
      XXXX

requests registration of the trademark/service mark identified above in the United States Patent and Trademark Office on the Principal Register established by the Act of July 5, 1946 (15 U.S.C. Section 1051 et seq.), as amended, for the following:

International Class 005:  Pharmaceutical preparations in the fields of pain relief, prevention, management and treatment; veterinary preparations in the fields of pain relief, prevention, management and treatment
Intent to Use: The applicant has a bona fide intention, and is entitled, to use the mark in commerce on or in connection with the identified goods/services.

International Class 042:  Research and development in the pharmaceutical field; consulting services in the field of pharmaceutical research and development; scientific research and development; scientific investigations for medical purposes; providing medical and scientific research information in the field of pharmaceuticals and clinical trials
Intent to Use: The applicant has a bona fide intention, and is entitled, to use the mark in commerce on or in connection with the identified goods/services.



The owner's/holder's proposed attorney information: Glenn A. Gundersen. Glenn A. Gundersen of Dechert LLP, is a member of the XX bar, admitted to the bar in XXXX, bar membership no. XXX, is located at
      Cira Centre
      2929 Arch Street
      Philadelphia, Pennsylvania 19104
      United States
      trademarks@dechert.com

Glenn A. Gundersen submitted the following statement: The attorney of record is an active member in good standing of the bar of the highest court of a U.S. state, the District of Columbia, or any U.S. Commonwealth or territory.

The applicant's current Correspondence Information:

Glenn A. Gundersen

PRIMARY EMAIL FOR CORRESPONDENCE: trademarks@dechert.com       SECONDARY EMAIL ADDRESS(ES) (COURTESY COPIES): NOT PROVIDED Requirement for Email and Electronic Filing: I understand that a valid email address must be maintained by the applicant owner/holder and the applicant owner's/holder's attorney, if appointed, and that all official trademark correspondence must be submitted via the Trademark Electronic Application System (TEAS).

A fee payment in the amount of $700 has been submitted with the application, representing payment for 2 class(es).

Declaration

	Basis: If the applicant is filing the application based on use in commerce under 15 U.S.C. § 1051(a): The signatory believes that the applicant is the owner of the trademark/service mark sought to be registered; The mark is in use in commerce and was in use in commerce as of the filing date of the application on or in connection with the goods/services in the application; The specimen(s) shows the mark as used on or in connection with the goods/services in the application and was used on or in connection with the goods/services in the application as of the application filing date; and To the best of the signatory's knowledge and belief, the facts recited in the application are accurate. And/Or If the applicant is filing the application based on an intent to use the mark in commerce under 15 U.S.C. § 1051(b), § 1126(d), and/or § 1126(e): The signatory believes that the applicant is entitled to use the mark in commerce; The applicant has a bona fide intention to use the mark in commerce and had a bona fide intention to use the mark in commerce as of the application filing date on or in connection with the goods/services in the application; and To the best of the signatory's knowledge and belief, the facts recited in the application are accurate.
	To the best of the signatory's knowledge and belief, no other persons, except, if applicable, concurrent users, have the right to use the mark in commerce, either in the identical form or in such near resemblance as to be likely, when used on or in connection with the goods/services of such other persons, to cause confusion or mistake, or to deceive.
	To the best of the signatory's knowledge, information, and belief, formed after an inquiry reasonable under the circumstances, the allegations and other factual contentions made above have evidentiary support.
	The signatory being warned that willful false statements and the like are punishable by fine or imprisonment, or both, under 18 U.S.C. § 1001, and that such willful false statements and the like may jeopardize the validity of the application or submission or any registration resulting therefrom, declares that all statements made of his/her own knowledge are true and all statements made on information and belief are believed to be true.

Declaration Signature

Signature: /Spencer Joffrion/   Date: 02/17/2023
Signatory's Name: Spencer Joffrion
Signatory's Position: Associate attorney, New York bar member
Signatory's Phone Number: Not Provided
Signature method: Sent to third party for signature
Payment Sale Number: 97800435
Payment Accounting Date: 02/17/2023

Serial Number: 97800435
Internet Transmission Date: Fri Feb 17 17:11:19 ET 2023
TEAS Stamp: USPTO/BAS-XXX.XXX.XXX.X-2023021717111999
9367-97800435-860a67daa52909afe215a3e3ae
279b42a1bb1db96e20f5a914295b4c137f61410-
DA-11196801-20230210155653490211